Israel released real-world research data of COVID-19 booster shot
- A Single US$2.15-Million Injection to Block 90% of Cancer Cell Formation
- WIV: Prevention of New Disease X and Investigation of the Origin of COVID-19
- Why Botulinum Toxin Reigns as One of the Deadliest Poisons?
- FDA Approves Pfizer’s One-Time Gene Therapy for Hemophilia B: $3.5 Million per Dose
- Aspirin: Study Finds Greater Benefits for These Colorectal Cancer Patients
- Cancer Can Occur Without Genetic Mutations?
Israel released real-world research data of COVID-19 booster shot
- Red Yeast Rice Scare Grips Japan: Over 114 Hospitalized and 5 Deaths
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Israel released real-world research data of COVID-19 booster shot.
On October 29, 2021, the Clalit Research Institute of Israel and the Ministry of Health published a blockbuster study on Lancet, reporting the real-world protection of more than 720,000 people inoculated with the third dose of BNT162b2.
The study evaluated the protective power of 7 days after the third dose of 728,321 and compared it with people who received only two doses of 728,321, all of whom received the second dose for more than 5 months.
Prevent an infection
The study showed that compared with subjects who received only 2 doses of vaccine, the third dose group had 88% protection against asymptomatic infections and 91% protection against symptomatic infections.
Prevention of severe illness and death
Compared with subjects who completed only 2 doses of vaccination, BNT162b2 booster vaccination had a 93% protection against hospitalization, 92% protection against critical illness, and 81% protection against death.
Real-world research in Israel shows that compared with standard vaccination, booster shots can significantly reduce the risk of infection, serious illness, and death.
The situation has changed in the United Kingdom, which has been slow to use booster needles, the United States, which partially uses booster needles, and Israel, which has fully used booster needles. As shown in 👇:
(Changes in new cases in the United Kingdom, the United States, and Israel)
As a global testing center for COVID-19, Israel took the unknown risk to overcome the obstacles of the global anti-epidemic countermeasures. The result is that the case fatality rate (0.61%) is much lower than that of the United Kingdom (1.56%) and the United States (1.62%).
This real-world protection data, together with Pfizer’s phase 3 clinical trial protection data, can be used as complete data on the effectiveness of the third dose of vaccination.
Reference:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02249-2/fulltext
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
